LifeStance Health (LFST) Non-Current Deferred Tax Liability (2020 - 2026)

LifeStance Health has disclosed Non-Current Deferred Tax Liability across 7 years of filings, most recently posting $16.4 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability rose 15.38% year-over-year to $16.4 million; the TTM figure through Mar 2026 stood at $16.4 million (up 15.38% YoY), while the FY2025 annual figure was $16.4 million, up 14.51% from the prior year.
• Non-Current Deferred Tax Liability steadied at $16.4 million in Q1 2026, from $16.4 million in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for LFST reached as high as $55.4 million in Q3 2022 and fell as low as $14.0 million in Q3 2025.
• The 5-year median for Non-Current Deferred Tax Liability is $16.4 million (2025), against an average of $27.6 million.
• Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability plunged 60.37% — and 2026, when it gained 15.38%.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $38.7 million in 2022, then tumbled by 59.76% to $15.6 million in 2023, then retreated by 7.98% to $14.3 million in 2024, then climbed by 14.51% to $16.4 million in 2025, then changed by 0.0% to $16.4 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $16.4 million, $16.4 million, and $14.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.